Several studies have demonstrated that chemotherapeutic agents, such as doxorubicin, docetaxel or anthracyclines enhance the expression of STAT1 and its activation in chemo-resistant cancer cells[11,12,14,32]. The gene discussed is STAT1; the disease is cancer.